These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 205163

  • 1. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB, Juhn DJ, Goldberg R, Rubenstein AH.
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [Abstract] [Full Text] [Related]

  • 2. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
    Kashyap ML, Srivastava LS, Chen CY, Perisutti CG, Campbell M, Lutmer RF, Glueck CJ.
    J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 4. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Jan; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 5. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Jan; 11(3):331-40. PubMed ID: 2743372
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G, Manzato E, Gabelli C, Fellin R, Martini S, Enzi GB, Verlato F, Baiocchi MR, Sprecher DL, Kashyap ML.
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia.
    Durrington PN, Bolton CH, Hartog M.
    Clin Chim Acta; 1978 Jan 02; 82(1-2):151-60. PubMed ID: 201398
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN, Le NA, Gibson JC.
    J Clin Invest; 1985 Feb 02; 75(2):614-23. PubMed ID: 3973021
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS, Alaupovic P, Gregg RE, Brewer HB.
    Biochim Biophys Acta; 1987 Jul 13; 920(1):9-19. PubMed ID: 3109493
    [Abstract] [Full Text] [Related]

  • 15. Studies in asymptomatic primary hyperlipidaemia. I. Types of hyperlipoproteinaemias and serum lipoprotein concentrations, compositions and interrelations.
    Olsson AG, Carlson LA.
    Acta Med Scand Suppl; 1975 Jul 13; 580():1-37. PubMed ID: 170799
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML, Srivastava LS, Hynd BA, Gartside PS, Perisutti G.
    J Lipid Res; 1981 Jul 13; 22(5):800-10. PubMed ID: 7288286
    [Abstract] [Full Text] [Related]

  • 17. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P, Schaefer EJ, McConathy WJ, Fesmire JD, Brewer HB.
    Metabolism; 1981 Aug 13; 30(8):805-9. PubMed ID: 6790903
    [Abstract] [Full Text] [Related]

  • 18. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C, Mahley RW, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL.
    Proc Natl Acad Sci U S A; 1984 Sep 13; 81(17):5566-70. PubMed ID: 6591204
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.